Astrotech Announces $10 Million Bought Deal Offering of Common Stock
Astrotech Corporation (NASDAQ: ASTC) has entered an underwriting agreement with H.C. Wainwright & Co. for the firm purchase of 6,666,667 shares of common stock at $1.50 per share, aiming for approximately $10 million in gross proceeds. The offering is set to close around April 12, 2021, pending customary conditions. An additional 1,000,000 shares may be sold under a 30-day option. The funds will be used for general corporate purposes and capital expenditures. The offering is part of a shelf registration statement effective March 15, 2021.
- Gross proceeds expected to be approximately $10 million.
- Funding will support general corporate purposes and capital expenditures.
- Potential dilution of existing shares due to the new offering.
Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,666,667 shares of common stock (or common stock equivalents in lieu thereof) of the Company at a price to the public of
H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.
The Company also has granted to the underwriter a 30-day option to purchase up to an additional 1,000,000 shares of common stock at the public offering price, less underwriting discounts and commission.
The gross proceeds of the offering are expected to be approximately
The securities described above are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-253835) filed with the Securities and Exchange Commission (SEC) and declared effective on March 15, 2021 and the accompanying prospectus contained therein. The offering of the securities is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to this offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov. Electronic copies of the preliminary prospectus supplement and the accompanying prospectus relating to this offering, when available, may also be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by e-mail at placements@hcwco.com or by calling (212) 856-5711.
This announcement is neither an offer to sell, nor a solicitation of an offer to buy, any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation, or sale is unlawful. Any offer, if at all, will be made only by means of the prospectus forming a part of the effective registration statement.
About Astrotech Corporation
Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including regarding the anticipated closing of the offering. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the public offering, the Company’s ability to obtain additional financing, the severity and duration of the COVID-19 pandemic and its impact on the U.S. and worldwide economy, the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, and whether the market will accept our products and services, market and other conditions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including our annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210407005961/en/
FAQ
What are the details of Astrotech's stock offering?
When is the closing date for Astrotech's stock offering?
What will Astrotech do with the proceeds from the offering?
Who is managing Astrotech's stock offering?
What is the potential impact of the stock offering on ASTC shareholders?
